- American City Business Journals•10 months ago
Cellular Dynamics International Inc. said Tuesday that it will supply its induced pluripotent stem cell-derived iCell products to Swiss pharmaceutical company Roche under a partnership that could provide up to $83 million in revenue for the Madison biotech firm. The supply and licensing agreement will give Roche exclusive access to specific iCell products to help identify novel drug candidates in the early stages of drug discovery. "Our partnerships with established leaders in the pharmaceutical industry, now including Roche, demonstrate that CDI products are increasingly becoming important tools for efficient drug discovery.
We're sorry this is all we were able to find about this topic.
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|